rs531275086
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_181705.4(LYRM7):c.2T>C(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000504 in 1,388,886 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_181705.4 start_lost
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LYRM7 | NM_181705.4 | c.2T>C | p.Met1? | start_lost | Exon 1 of 5 | ENST00000379380.9 | NP_859056.2 | |
LYRM7 | NM_001293735.2 | c.2T>C | p.Met1? | start_lost | Exon 1 of 4 | NP_001280664.1 | ||
LYRM7 | NR_121658.2 | n.79T>C | non_coding_transcript_exon_variant | Exon 1 of 3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LYRM7 | ENST00000379380.9 | c.2T>C | p.Met1? | start_lost | Exon 1 of 5 | 1 | NM_181705.4 | ENSP00000368688.4 | ||
LYRM7 | ENST00000507584.1 | c.2T>C | p.Met1? | start_lost | Exon 1 of 4 | 2 | ENSP00000423991.1 | |||
LYRM7 | ENST00000510516.5 | c.2T>C | p.Met1? | start_lost | Exon 1 of 3 | 2 | ENSP00000423283.1 | |||
HINT1 | ENST00000506207.2 | n.236+584A>G | intron_variant | Intron 2 of 3 | 5 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000172 AC: 3AN: 174826Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 96614
GnomAD4 exome AF: 0.00000504 AC: 7AN: 1388886Hom.: 0 Cov.: 30 AF XY: 0.00000435 AC XY: 3AN XY: 689134
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial complex III deficiency nuclear type 8 Pathogenic:4
A Homozygote Start lost variant c.2T>C in Exon 1 of the LYRM7 gene that results in the amino acid substitution p.Met1? was identified. The observed variant has a minor allele frequency of 0.00002% in gnomAD exomes and novel genomes, respectively. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score . Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13 individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic (Variant ID: 1323256).This disorder has previously been reported in mitochorial cmplex II (Molina-Berenguer M et al 2022). Based on the above evidence this variant has been classified as Likely Pathogenic according to the ACMG guidelines. -
The observed start lost c.2T>C(p.Met1?) variant in LYRM7 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is reported with the allele frequency of 0.002% in the gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic. The p.Met1? variant is predicted to disrupt the initiation codon, and thus potentially may interfere with protein expression. For these reasons, this variant has been classified as Likely Pathogenic. -
- -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at